According to a recent study, MCAM and its extracellular matrix interaction partner LAMA4, highly expressed in locally advanced tumors as well as secondary metastases, were predictive markers for poor RCC prognosis22. The gene discussed is MCAM; the disease is renal cell adenocarcinoma.